Review decision date: July 2011
Following the recent review recommendation, an update of this guideline is currently in the process of being scheduled into the work programme. Details of any update will be available on the guidelines in development webpage.
The NICE guideline on Parkinson's disease covers:
- the diagnosis of Parkinson's disease and checking the diagnosis regularly
- the way people with Parkinson's disease should receive information
- the medicines that can be used
- other ways of helping with symptoms
- how to care for people whose mental health is affected
- the care people with Parkinson's disease should receive at the end of their life
This guideline was previously called Parkinson's disease: diagnosis and management in primary and secondary care.
Responsibility for undertaking a review of this guidance at the designated review date has passed to the National Clinical Guidelines Centre for Acute and Chronic Conditions (NCGC-ACC). The National Collaborating Centre for Chronic Conditions is no longer active.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.